ACVRL1 and pulmonary arterial hypertension: In a few PAH patients mutations in other genes participating in the BMPR2 signalling pathway have been identified, as Activin A receptor type II-like 1 (ACVRL1, also called ALK1) [8], Endoglin [9], and SMAD8 [10].